Follow this preprint
Extreme γ’ fibrinogen levels in COVID-19 patients
David H. Farrell, Matthew Hudkins, Heather Hamilton, Samantha J. Underwood, Elizabeth N. Dewey, Diana E. Kazmierczak, Steven C. Kazmierczak, William B. Messer, Akram Khan, Martin A. Schreiber
doi: https://doi.org/10.1101/2022.01.20.22269321
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
David H. Farrell
aDepartment of Surgery, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Matthew Hudkins
bDepartment of Pediatrics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Heather Hamilton
aDepartment of Surgery, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Samantha J. Underwood
aDepartment of Surgery, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Elizabeth N. Dewey
aDepartment of Surgery, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Diana E. Kazmierczak
cDepartment of Pathology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Steven C. Kazmierczak
cDepartment of Pathology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
William B. Messer
dDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Akram Khan
eDepartment of Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA
Martin A. Schreiber
aDepartment of Surgery, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239 USA

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 21, 2022.
Extreme γ’ fibrinogen levels in COVID-19 patients
David H. Farrell, Matthew Hudkins, Heather Hamilton, Samantha J. Underwood, Elizabeth N. Dewey, Diana E. Kazmierczak, Steven C. Kazmierczak, William B. Messer, Akram Khan, Martin A. Schreiber
medRxiv 2022.01.20.22269321; doi: https://doi.org/10.1101/2022.01.20.22269321
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (734)
- Anesthesia (215)
- Cardiovascular Medicine (3142)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13106)
- Forensic Medicine (15)
- Gastroenterology (873)
- Genetic and Genomic Medicine (4923)
- Geriatric Medicine (453)
- Health Economics (758)
- Health Informatics (3104)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (978)
- Medical Education (459)
- Medical Ethics (121)
- Nephrology (507)
- Neurology (4684)
- Nursing (248)
- Nutrition (692)
- Oncology (2414)
- Ophthalmology (688)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1254)
- Primary Care Research (526)
- Public and Global Health (7244)
- Radiology and Imaging (1619)
- Respiratory Medicine (949)
- Rheumatology (463)
- Sports Medicine (407)
- Surgery (522)
- Toxicology (65)
- Transplantation (223)
- Urology (193)